142 related articles for article (PubMed ID: 33781724)
1. Frozen versus fresh corneal graft carriers in Boston keratoprosthesis surgery: 10-year outcomes.
Sabeti S; Daoud R; Robert MC; Harissi-Dagher M
Can J Ophthalmol; 2022 Apr; 57(2):127-133. PubMed ID: 33781724
[TBL] [Abstract][Full Text] [Related]
2. Boston Keratoprosthesis Type 1: A Randomized Controlled Trial of Fresh versus Frozen Corneal Donor Carriers with Long-Term Follow-up.
Muzychuk AK; Robert MC; Dao S; Harissi-Dagher M
Ophthalmology; 2017 Jan; 124(1):20-26. PubMed ID: 27566854
[TBL] [Abstract][Full Text] [Related]
3. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
Robert MC; Biernacki K; Harissi-Dagher M
Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
[TBL] [Abstract][Full Text] [Related]
4. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
[TBL] [Abstract][Full Text] [Related]
5. Boston type I keratoprosthesis versus penetrating keratoplasty following a single failed corneal graft.
El-Khoury J; Khair D; Daoud R; Thompson P; Racine L; Harissi-Dagher M
Eye (Lond); 2023 Feb; 37(3):486-491. PubMed ID: 35169272
[TBL] [Abstract][Full Text] [Related]
6. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
[TBL] [Abstract][Full Text] [Related]
7. [Long-term visual outcomes of Boston type I keratoprosthesis in Canada].
Aoun T; Harissi-Dagher M
J Fr Ophtalmol; 2023 Dec; 46(10):1212-1221. PubMed ID: 37867123
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes following primary versus secondary Boston keratoprosthesis type 1 implantation.
Nayman T; Bostan C; Szigiato AA; Harissi-Dagher M
Br J Ophthalmol; 2022 Jul; 106(7):935-940. PubMed ID: 33622700
[TBL] [Abstract][Full Text] [Related]
9. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada.
Szigiato AA; Bostan C; Nayman T; Harissi-Dagher M
Br J Ophthalmol; 2020 Nov; 104(11):1601-1607. PubMed ID: 32066560
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of bilateral sequential implantation of the Boston keratoprosthesis type 1.
Vaillancourt L; Papanagnu E; Elfekhfakh M; Fadous R; Harissi-Dagher M
Can J Ophthalmol; 2017 Feb; 52(1):80-84. PubMed ID: 28237154
[TBL] [Abstract][Full Text] [Related]
11. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
[TBL] [Abstract][Full Text] [Related]
12. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
[TBL] [Abstract][Full Text] [Related]
13. Glaucoma associated with Boston type I keratoprosthesis.
Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
[TBL] [Abstract][Full Text] [Related]
14. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
Geoffrion D; Harissi-Dagher M
Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
[TBL] [Abstract][Full Text] [Related]
15. Vitreoretinal Complications in Boston Keratoprosthesis Type 1.
Khair D; Salimi A; Harissi-Dagher M
Am J Ophthalmol; 2021 Nov; 231():101-108. PubMed ID: 34107311
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients.
Geoffrion D; Hassanaly SI; Marchand M; Daoud R; Agoumi Y; Harissi-Dagher M
Am J Ophthalmol; 2022 Mar; 235():249-257. PubMed ID: 34543660
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of the Boston type 1 and the Aurolab keratoprosthesis in eyes with limbal stem cell deficiency.
Shanbhag SS; Senthil S; Mohamed A; Basu S
Br J Ophthalmol; 2021 Apr; 105(4):473-478. PubMed ID: 32554443
[TBL] [Abstract][Full Text] [Related]
18. Outcomes and complications of Boston keratoprosthesis type I implantation in unilateral versus bilateral corneal blindness.
Touma S; Harissi-Dagher M
Can J Ophthalmol; 2021 Apr; 56(2):130-136. PubMed ID: 33002416
[TBL] [Abstract][Full Text] [Related]
19. Management of corneal melt in patients with Boston Keratoprosthesis Type 1: Repair versus repeat.
Daoud R; Sabeti S; Harissi-Dagher M
Ocul Surf; 2020 Oct; 18(4):713-717. PubMed ID: 32777438
[TBL] [Abstract][Full Text] [Related]
20. Boston type 1 keratoprosthesis: the CHUM experience.
Robert MC; Harissi-Dagher M
Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
